Delivery Order SPE2DB20D1100-SPE2DB25FE1G5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 tablets, with a ceiling value of $2,211.04. This contract is a firm fixed price delivery order with an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the vendor's...
- The Defense Logistics Agency awarded a $2,207.23 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 2, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The place of performance is the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units, with a ceiling value of $5,863.25 and a completion date of July 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply framework. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,739.94 for 100 tablets of Glimepiride 4 mg on August 25, 2025, with completion anticipated by August 26, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Glimepiride is an oral antidiabetic medication commonly utilized in military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units at a ceiling value of $1,606.70. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19,...
- The Defense Logistics Agency awarded a delivery order valued at $1,266.96 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed-price contract with no set-aside designation, competitively awarded on August 25, 2025, with an ultimate completion date of August 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,157.52 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a $1,784.23 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg, a generic medication commonly used in diabetes management. This firm fixed price, competitively awarded delivery order was finalized on August 11, 2025, with an ultimate completion date of August 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This award carries no...
- The Defense Logistics Agency awarded a delivery order valued at $5,217.54 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of Glimepiride 4 mg tablets (100-count units) at a ceiling value of $2,785.80. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by May 14, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1G5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,750.74 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order operates as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to support military healthcare programs worldwide. Glimepiride, a diabetes management medication, aligns with the company's extensive portfolio of pharmaceutical products delivered through the Defense Logistics Agency's Medical Supply Chain to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/18/25 |